Skip to content

Intelligent Management throughout the Full Course of COVID-19 for High-Risk Individuals with Severe Symptoms Using Multi-Physiological Sensing Devices

Intelligent Management throughout the Full Course of COVID-19 for High-Risk Individuals with Severe Symptoms Using Multi-Physiological Sensing Devices

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091462
Enrollment
Unknown
Registered
2024-10-29
Start date
2024-10-31
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Sponsors

Beijing Ditan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Study population: people at high risk of severe illness from novel coronavirus infection (meeting any of the following enrollment criteria) (1) Elderly people aged =65 years; (2) Having cardiovascular and cerebrovascular diseases (including hypertension), chronic lung diseases, diabetes mellitus, chronic liver and kidney diseases, tumors and other underlying diseases as well as maintenance dialysis patients; (3) Immunodeficiency (e.g. AIDS patients, long-term use of corticosteroids or other immunosuppressive drugs leading to immunodeficiency) (4) Obese patients [body mass index (BMI) greater than 30]; (5) Late pregnancy and perinatal women; (6) Heavy smokers.

Exclusion criteria

Exclusion criteria: (1) Patients who are unable to follow the study protocol, including those with mental illnesses, etc. (2) Those who refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Indicators for monitoring multisignature sensing devices;

Secondary

MeasureTime frame
AUC;Systemic and respiratory symptoms;Imaging information;Laboratory test indicators;

Countries

China

Contacts

Public ContactSong Rui

Beijing Ditan Hospital, Capital Medical University

13126595640@163.com+86 131 2659 5640

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026